PLA2G4A and neoplasm: PIK3CA mutations drive multiple signaling networks involving mTORC2-PKCζ-mediated activation of cPLA2, and cPLA2 inhibition and dietary fat restriction restore tumor immune cell infiltration and inhibit breast tumor growth 149.